Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

BACKGROUND AND PURPOSE: To compare the efficacy and safety of antiplatelet agents for the secondary prevention of ischemic stroke based on cytochrome P450 2C19 (CYP2C19) polymorphisms. METHODS: This study was a prospective, multicenter, randomized, parallel-group, open-label, blind genotype trial. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sang Won, Kim, Yong-Jae, Ahn, Seong Hwan, Seo, Woo-Keun, Yu, Sungwook, Oh, Seung-Hun, Nam, Hyo Suk, Choi, Hye-Yeon, Yoon, Sung Sang, Kim, Seo Hyun, Lee, Jong Yun, Lee, Jun Hong, Hwang, Yang-Ha, Lee, Kee Ook, Jung, Yo Han, Lee, Jun, Sohn, Sung-Il, Kim, Youn Nam, Lee, Kyung-A, Bushnell, Cheryl D, Lee, Kyung-Yul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647640/
https://www.ncbi.nlm.nih.gov/pubmed/29037010
http://dx.doi.org/10.5853/jos.2017.01249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647640/
https://www.ncbi.nlm.nih.gov/pubmed/29037010
http://dx.doi.org/10.5853/jos.2017.01249

Ejemplares similares